PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 06: Articles 2501-3000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Post-Soviet contraceptive practices and abortion rates in St. Petersburg, Russia.
  2. Preclinical profiles of progestins used in formulations of oral contraceptives and hormone replacement therapy.
  3. Preliminary examination of oral contraceptive use among university-aged females.
  4. A prospective study evidencing rhinomanometric and olfactometric outcomes in women taking oral contraceptives.
  5. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation.
  6. A prospective, controlled study of the effects of hormonal contraception on bone mineral density.
  7. Quality of care and contraceptive pill discontinuation in rural Egypt.
  8. RASA, a recombinant single-chain variable fragment (scFv) antibody directed against the human sperm surface: implications for novel contraceptives.
  9. Regional variation in acceptance of Indonesia's family planning program.
  10. The relationship between use of oral contraceptives and myocardial infarction in young women with fatal outcome, compared to those who survive: results from the MICA case-control study.
  11. Religion, social milieu, and the contraceptive revolution. [Religion, milieu social, et révolution contraceptive.]
  12. Repeat use of contraceptive crisis services among adolescent women. [Usage répété des services contraceptifs de crise chez les adolescentes.]
  13. Repeat use of emergency contraception: How frequent is it?
  14. Reproductive and contraceptive attitudes as predictors of condom use among women in an HIV prevention intervention.
  15. Return of fertility in nulliparous women after discontinuation of the intrauterine device: comparison with women discontinuing other methods of contraception.
  16. Risk of venous thromboembolism from oral contraceptives containing gestodene and desogestrel versus levonorgestrel: a meta-analysis and formal sensitivity analysis.
  17. The role of changes in contraceptive use in the decline of induced abortion in Turkey.
  18. Ruling opens door for coverage of prescription contraceptives. [Un jugement qui ouvre la porte à la couverture des contraceptifs prescrits par ordonnance.]
  19. Rural and urban midwestern United States contraception practices.
  20. Savings / credit group formation and change in contraception.
  21. Sex preference and contraceptive behaviour among men in Mbeya region, Tanzania.
  22. Sexual behaviour and contraceptive use among unmarried, young women migrant workers in five cities in China.
  23. Side effects and oral contraceptive discontinuation in rural Bangladesh.
  24. Some evidence against the assumption that approval of family planning is associated with frequency of spouses' discussion of the subject.
  25. Swedish teenagers' attitudes toward the emergency contraceptive pill.
  26. A tale of 2 cities: a comparison of demographic details, source of referral, spectrum of infection and contraceptive practice in patients under 16 years attending genitourinary medicine clinics in London and Swansea.
  27. Testosterone for male contraception during one year: attitudes, well-being and quality of sex life.
  28. Third-generation progestogen type influences hemostatic changes caused by oral contraceptives in Brazilian women.
  29. Tissue response to the STOP microcoil transcervical permanent contraceptive device: results from a prehysterectomy study.
  30. Use of contraceptive methods among homeless women for protection against unwanted pregnancies and sexually transmitted diseases: prior use and willingness to use in the future.
  31. Use of contraceptive methods in Spain: results of a national survey.
  32. Use of the combined oral contraceptive pill by under 16s. [Utilisation de la pilule contraceptive orale combinée par les moins de 16 ans.]
  33. Views of Chinese parents on the provision of contraception to unmarried youth.
  34. Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials.
  35. When a man is with a women, it feels like electricity: subjectivity, sexuality and contraception among men in central Mexico.
  36. Why is contraceptive use inversely associated with lactational amenorrhoea? Qualitative and quantitative insights from Bangladesh.
  37. Why it is difficult to determine resource requirements for family planning.
  38. Women's reasons for discontinuing contraceptive use within 12 months: Jamaica.
  39. Young people's contraception and sexual health : report of a local needs assessment in Staveley, North Derbyshire. [Contraception et santé sexuelle des jeunes : rapport sur l'évaluation des besoins à Staveley, au Derbyshire du Nord.]
  40. Young women requesting emergency contraception are, despite contraceptive counseling, a high risk group for new unintended pregnancies.
  41. The Mexico City policy and U.S. family planning assistance.
  42. Reproductive Health Research Group, Northwest Frontier Province, Pakistan. Family planning continuation study 2000. Study report: Family planning continuation among Afghan refugees in Northwest Frontier Province, Pakistan.
  43. Contraceptive methods.
  44. Family planning program issues.
  45. New contraceptive approaches in 2001. [Novedades anticonceptivas en el 2001.]
  46. Findings from the Amhara and Oromia Demographic Surveys: fertility and contraceptive use in the Amhara and Oromia Regions.
  47. Findings from the Amhara and Oromia Demographic Surveys: childbearing and family planning - experience, knowledge, and intentions.
  48. El Salvador. Community health promoters provide family planning.
  49. Benin: responsive training and learning. Training pharmacists as family planning providers. [Bénin : formation réactive et apprentissage. La formation de pharmaciens à la fonction de fournisseurs des services de planning familial.]
  50. Strategy for family planning program recovery in Nigeria.
  51. Bush reinstates policy restricting support for international family planning programs.
  52. Most European women use contraceptives, yet some still have surprise pregnancies.
  53. Operations research in reproductive health and family planning at Cairo Demographic Center.
  54. Obstacles to contraceptive use in Pakistan: a study in Punjab.
  55. An assessment of the Zimbabwe National Family Planning Council's Community Based Distribution Programme.
  56. Expansion of postpartum / postabortion contraception in Honduras. [Expansión de la anticoncepción postparto o postaborto en Honduras.]
  57. Gene and protein identified, offer promising targets for male contraceptive.
  58. Obstacles to contraceptive use in Pakistan. Unmet need.
  59. Honduras: contraceptive choice. Postpartum and postabortion patients want family planning. [Honduras: elección anticonceptiva. Las puérperas y las pacientes que han sufrido un aborto desean planificación familiar.]
  60. Issues and strategies for sustainability of family planning services in Egypt. A background analysis paper.
  61. State-by-state report card on access to contraception.
  62. The contraception report: a state-by-state review of access to contraception.
  63. A male contraceptive?
  64. The contraception-fertility link in sub-Saharan Africa and in other developing countries.
  65. Medicaid coverage of family planning services: results of a national survey.
  66. Intravesical migration of intrauterine contraceptive device.
  67. Emergency contraception is just that ... emergency contraception, not abortion.
  68. Iranian miracle: How to raise contraceptive prevalence rate to above 70% and cut TFR by two-thirds in less than a decade?
  69. Men and contraception: a study on middle-class Brazilian men. [Los hombres y la anticoncepción: estudio sobre hombres brasileños de clase media.]
  70. Men and family planning in Iran.
  71. The past, present and future of family planning in Portugal.
  72. Bush decision threatens international family planning: gag rule will hurt programs that reduce unplanned pregnancies and abortion. Press release.
  73. Expansion of emergency contraception in the direction of global access. A collaborative strategy to meet women's needs. [Expansion de la anticoncepcion de emergencia hacia el acceso global. Una estrategia colaborativa para satisfacer las necesidades de la mujeres.]
  74. IPPF / WHR gagged by President Bush: return of Mexico City Policy threatens efforts to reach millions with family planning.
  75. At your service? Family planning programmes in Bangladesh.
  76. The Planned Parenthood Association of Thailand: prevention of domestic violence against women and children in Thailand through the promotion of reproductive health.
  77. Bridging the gap: integrating family planning with abortion services in Turkey.
  78. Client donations for contraceptives: an innovative approach to sustainable financing in Turkey.
  79. Contraceptive projections and the donor gap. Meeting the challenge.
  80. Toward contraceptive self-reliance in Turkey: results from a pilot test of a cost-sharing mechanism. Full report.
  81. Contraceptive prevalence in a peri-urban area of Sousse, Tunisia. [La prévalence contraceptive dans une zone périurbaine de la ville de Sousse (Tunisie)]
  82. The determinants of fertility in rural Peru: program effects in the early years of the National Family Planning Program. [Factores determinantes de fertilidad en zonas rurales de Perú: efectos del Programa Nacional de Planificación Familiar durante sus primeros años de aplicación.]
  83. Relationships between abortion and contraception in republics of the former Soviet Union.
  84. Enhancing NGO-LGU collaboration in family planning: using community workers to reach men in an agrarian setting.
  85. A meta-analysis of the impact of family planning programs on fertility preferences, contraceptive method choice and fertility.
  86. International family planning: the "Mexico City" policy. Updated April 2, 2001. CRS report for Congress. [Planificación familiar internacional: la política "Ciudad de México". Actualizado al 2 de abril de 2001. Informe del Servicio de Investigación del Congreso (CRS, por sus siglas en inglés) para el Congreso de Estados Unidos.]
  87. Contraceptive use dynamics in Kenya. Further analysis of Demographic and Health Survey (DHS) data.
  88. Quick Investigation of Quality (QIQ). A user's guide for monitoring quality of care in family planning.
  89. The contraception-adoption process in Jordan. Prospective study.
  90. Perceptions of contraceptives among women in Jordan. A projective study.
  91. Release of progestin-only emergency contraception.
  92. New options in contraception for adolescents.
  93. Vas deferens, a site of male contraception: an overview.
  94. Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria.
  95. Using photographs to strengthen family planning research.
  96. Contraceptive use elevates the odds of barrier method use for disease prevention.
  97. Many women at high risk for unintended pregnancy are unaware of emergency contraception or how to use it.
  98. Improving youth's access to contraception in Latin America. [Mejoramiento del acceso de los jóvenes a los métodos anticonceptivos en América Latina.]
  99. Do magazines inform young women about emergency contraception?
  100. Breast and pelvic examination not necessary before prescribing hormonal contraception. Current research.
  101. Emergency contraceptive pills -- a fact sheet.
  102. Emergency contraceptive pills -- an important option for teens.
  103. Pharmacists' attitudes and awareness of emergency contraception for adolescents.
  104. Teens and emergency contraceptive pills: issues for health care providers and educators.
  105. Informed choice in family planning. Helping people decide./Programas de planejamento familiar-escolhas bem informadas de planejamento familiar./Le choix eclaire en planification familiale-aider a choisir./Eleccion informada en la planificacion familiar-como ayudar a la gente a decidir. [Programas de Planejamento Familiar - Escolhas bem informadas de planejamento familiar.]
  106. Ambition may be best contraception [letter]
  107. Contraception in general practice before teenage pregnancy. Inappropriate selection of cases and controls biased study [letter]
  108. Emergency contraception from pharmacists misses opportunity [letter]
  109. Improving access to emergency contraception. Allowing pharmacy sales should help reduce unwanted pregnancies [editorial]
  110. Intrauterine device may not be most suitable method of contraception for teenagers [letter]
  111. US judge condemns health plan for not covering contraception.
  112. Value of family history in identifying women at risk of venous thromboembolism during oral contraception: observational study.
  113. Family-planning services in a low-performing rural area of Bangladesh: insights from field observations.
  114. Oral contraception and benign ovarian cysts.
  115. Oral contraception and uterine fibroids.
  116. The oral contraceptive pill in Viet Nam: situation, client perspectives and possibilities for promotion.
  117. Oral contraceptive pill use and pelvic inflammatory disease.
  118. Oral contraceptive use is associated with increased cardiovascular reactivity in nonsmokers.
  119. Oral contraceptive with unique progestin receives FDA approval. [La FDA approuve la contraception orale avec la progestine seule.]
  120. Oral contraceptives and bone mineral density [letter] [Contraceptifs oraux et densité minérale des os] [lettre.]
  121. Oral contraceptives and bone mineral density. Reply [letter] [Contraceptifs oraux et densité minérale des os. Réponse] [lettre.]
  122. Oral contraceptives and breast cancer risks.
  123. Oral contraceptives and breast cancer: a case-control study. [Contraceptivos orais e cancer de mama: estudo de casos e controles.]
  124. Oral contraceptives and cancer: an update.
  125. Oral contraceptives and cardiovascular disease risk in Black and White women: the CARDIA study.
  126. Oral contraceptives and central retinal vein occlusion [letter]
  127. Oral contraceptives and congenital thrombophilia. [Anticonceptivos orales y trombofilia congenita.]
  128. Oral contraceptives and myocardial infarction -- the search for the smoking gun [editorial]
  129. Oral contraceptives and the risk of venous thrombosis.
  130. Oral contraceptives increase the plasma concentrations of chlorpromazine.
  131. Oral contraceptives, exercise, and acute mountain sickness in women.
  132. Oral contraceptives.
  133. Oral contraceptives: an update on health benefits and risks.
  134. Oral contraceptives: current status.
  135. Oral hormonal contraceptives, coagulation and thrombosis (editorial) [Anticonceptivos hormonales orales, coagulacion y trombosis.]
  136. Osteoporosis and hormonal contraception. [Osteoporoza a hormonalni- kontracepce.]
  137. Ovarian abscess due to Actinomyces sp. in absence of an intrauterine contraceptive device (IUD) [Absceso ovarico por Actinomyces sp. en ausencia de un dispositivo intrauterino.]
  138. Contraceptive vaccine: new hope for the overcrowded world?
  139. Contraceptive vaginal rings.
  140. Contraceptives do not protect against pelvic inflammatory disease.
  141. Contraceptives for epileptics? [Kontrazeptiva fur Epileptikerinnen?]
  142. Country perspectives on the future of contraceptive supplies.
  143. Court ruling advances contraceptive coverage.
  144. Current and past contraceptive use.
  145. Current options for injectable contraception in the United States.
  146. Cystic fibrosis and contraception. [Fibrosis quística y contracepción.]
  147. Daily testosterone and gonadotropin levels are similar in azoospermic and nonazoospermic normal men administered weekly testosterone: implications for male contraceptive development.
  148. A multinational evaluation of the efficacy, safety and acceptability of the Protectaid contraceptive sponge.
  149. Natural family planning: the various components.
  150. Natural methods of contraception.
  151. Navigating the boundaries: promoting family planning in the mass media in Pakistan.
  152. Need for contraceptive services.
  153. The need for more active promotion of emergency contraception [Editorial]
  154. Neisseria gonorrhoeae and Chlamydia trachomatis infections in patients attending STD and family planning clinics in Bissau, Guinea-Bissau. [Infection de Neisséria gonorrhoeae et de Chlamydia trachomatis chez les patients des cliniques MST et de planning familial à Bissau, en Guinée Bissau.]
  155. New approaches to emergency contraception.
  156. New contraceptive options.
  157. New developments in contraception featuring the levonorgestrel intrauterine system (LNG IUS)
  158. New rules issued to govern delivery of family planning under Medicaid managed care.
  159. New WHO medical eligibility criteria for contraceptives: adaptation for use in a local service in UK.
  160. News flash: Add new 25-mcg Cyclessa to triphasic oral contraceptive options.
  161. The next step for emergency contraception: over-the-counter availability.
  162. NGOs and family planning in Egypt.
  163. NHS contraceptive services: key facts.
  164. Non-hormonal methods of contraception.
  165. Non-oral hormonal contraceptives: injectables, implants and vaginal rings.
  166. Noncontraceptive benefits and therapeutic uses of the oral contraceptive pill.
  167. Norplant and other implantable contraceptives.
  168. Norplant Foundation: visioning the future of long-acting and intermediate-acting contraception.
  169. A novel contraceptive vaccine: design and synthesis of the chimeric peptide containing multivalent sperm-specific epitopes.
  170. Nurse-midwives' knowledge and promotion of lactational amenorrhea and other natural family-planning methods for child spacing.
  171. OC use: improving contraceptive success.
  172. The occupational profile and associated training needs of the nurse prescriber: an empirical study of family planning nurses.
  173. Descriptive analysis of the activities of the maternal health and family planning programs, 2000. [Analyse descriptives des activites des programmes de la sante de la mere et de planification familiale, 2000.]
  174. The determinants of contraceptive method use in Cote d'Ivoire. [Les determinants de l'utilisation des methodes contraceptives en Cote-d'Ivoire.]
  175. Determinants of unmet need for family planning in squatter settlements in Karachi, Pakistan.
  176. DHS qualitative study examines reasons for contraceptive discontinuation in Philippines.
  177. Diabetes and depot medroxyprogesterone contraception in Navajo women.
  178. Did family planning service delivery guidelines improve provider practices in Ghana, 1993-2000? Final report.
  179. Differentiation in contraceptive behavior of the female population in Thrace, Greece.
  180. Difficulties in access to contraception. [Dificuldades no acesso a contracepcao.]
  181. Do contraceptives offer protection against PID?
  182. Do men need family planning services in Jordan?
  183. Does adding estrogen to the hormone-free days of an oral contraceptive (OC) cycle reduce menopausal symptoms in perimenopausal OC users?
  184. The acceptability of the female condom: perspectives of family planning providers in New York City, South Africa, and Nigeria.
  185. Access to emergency contraception in the United States [editorial]
  186. Administration promoting abstinence. Family planning efforts are being scaled back.
  187. Administration softens stance on Medicaid family planning waivers.
  188. Administration's new Medicaid rules could limit family planning.
  189. Adolescent contraception and the clinician: an emphasis on counseling and communication.
  190. Adolescents and contraception. What should the pediatrician know? (Part one) [Les adolescents et la contraception. Que devrait savoir le pediatre? (1re partie)]
  191. Adolescents' use of emergency contraception provided by Washington State pharmacists.
  192. Adoption of family planning: Does it empower women? An empirical investigation. Abstract.
  193. Advances in male hormonal contraception.
  194. AIDS and contraception. Unanticipated effects of AIDS prevention campaigns.
  195. Al Hilal: the injectable contraceptive: an additional choice. [Al Hilal. Le contraceptif injectable: un choix supplémentaire.]
  196. Albanian Family Planning Association and legislation.

     

  197. Analysis of failure time hierarchical data in the presence of competing risks with application to oral contraceptive pill use in Egypt.
  198. Analysis on the attitude of the family planning staff toward the contraception service delivery to the unmarried youth.
  199. Andromeda freed from her chains: attitudes towards women and the oral contraceptive pill, 1950-1970.
  200. Are adolescents and young adults more likely than are older women to choose commercial and private sector providers of modern contraception?
  201. Aspects of contraceptive methods used in Sao Paulo State, Brazil. [Características do uso de métodos anticoncepcionais no Estado de Sao Paulo.]
  202. Assessing the appropriateness of user fees for family planning services in Malawi.
  203. Assessment of the implementation of the Tiahrt amendment in USAID / Indonesia-supported family planning projects. [Evaluation de la mise en ouvre de l'amendement Tiahrt dans le cadre des projets de planning familial soutenus par l'USAID et l'Indonésie.]
  204. Attitudes and opinions about contraception and abortion.
  205. Attitudes and practices of pharmacists towards emergency contraception in Durban, South Africa.
  206. Attitudes of family planning workers toward setting up special counseling stations for unmarried young adults.
  207. Barrier contraceptives.
  208. Behaviour change communication strategy on population and reproductive health / family planning, 2001-2005.
  209. Benefits of modern contraceptives. [Avantages des contraceptifs modernes.]
  210. Birth control for men and women. Three new methods could change the face of contraception.
  211. Birth control: an open letter.
  212. Birth control: comparing the choices.
  213. Blood pressure stability in a normotensive population during intake of a monophasic oral contraceptive containing 20 micrograms ethinylestradiol and 75 g gestodene.
  214. Body weight change during use of a monophasic oral contraceptive containing 20 micrograms ethinylestradiol and 75 micrograms gestodene with a comparison of the women who completed versus those who prematurely discontinued intake.
  215. Boost knowledge of emergency contraception.
  216. Breaking the myth of low family planning coverage in Africa.
  217. In brief. [American College of Obstetricians and Gynecologists (ACOG) endorses the availability of emergency contraception "over the counter in a designated product"]
  218. Bringing emergency contraception to American women: the history and remaining challenges.
  219. Calendar method unreliable; switch to natural family planning instead.
  220. Campaign touts family planning benefits for mothers and children.
  221. Can hormonal contraception influence plasma levels of IGF-1 and IGEBP-1 in gracile women with polycystic ovary syndrome? [Muze hormonalni antikoncepce ovlivnit plazmatickou koncentraci IGF-1 a IGFBP-1 stihlych se syndromem polycystickych ovarii?]
  222. Can progress be made in contraception? (editorial) [Des progres sont-ils a faire en contraception? Editorial.]
  223. Cardiovascular risks associated with the use of low-dose combined oral contraceptives. [Kardiovaskuläre Risiken unter der Mikropille.]
  224. Catholic paper pulls anti-emergency contraception ads.
  225. Challenges facing family planning clinics and Title X.
  226. Challenges facing family planning clinics and Title X.
  227. Changes of major population and family planning indicators (1996-2000)
  228. The Chinese experience with elastomer vas deferens occlusion for reversible contraception [letter]
  229. Choice of contraception (for the individual, teenagers, lactating mothers, middle-aged and premenopausal women, and for women with medical disorders)
  230. Choice of contraception.
  231. Choices in family planning: informed and voluntary decision making. Work in progress.
  232. Choosing an injectable contraceptive.
  233. Combined contraceptive vaginal ring awaiting US approval.
  234. Combined oral contraceptive pill (OCP) as treatment for primary dysmenorrhoea.
  235. Commissioned review: The national strategy for sexual health and HIV: a perspective from family planning.
  236. Community health centers and family planning.
  237. Community health centers and family planning: what we know.
  238. Community participation in the Bangladesh health and family planning program: dissemination activities and lessons learned.
  239. Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate.
  240. Concurrent use of oral contraceptives with antidepressants for premenstrual syndromes [letter]
  241. The conflict between profits and public health: a comparison of contraceptive social marketing models.
  242. Contraception (editorial) [Editorial. Empfangnisverhutung.]
  243. Contraception adapted to each woman. [Une contraception adaptee pour chaque femme.]
  244. Contraception after intercourse.
  245. Contraception and abortions. [Kontraception og aborter.]
  246. Contraception and pregnancy after liver transplantation.
  247. Contraception during lactation.
  248. Contraception for the 21st century.
  249. Contraception for women in the perimenopause.
  250. Contraception in adolescence and the perimenopause.
  251. Contraception in immigrant women. [Antikonzeption bei Migrantinnen.]
  252. Contraception in Jordan : a cultural and religious perspective. [Contraception en Jordanie : point de vue culturel et religieux.]
  253. Contraception in Mexico. [Anticoncepción en México.]
  254. Contraception in poor countries: a fertile future?
  255. Contraception in primary care.
  256. Contraception in rural Maharashtra.
  257. Contraception in the perimenopause.
  258. Contraception, unintended pregnancies, and sexually transmitted infections. Still no simple solutions.
  259. Contraception.
  260. Contraception. The implant: a good plan. [Contraception. L'implant: un bon plan.]
  261. Contraception: myths, facts and methods.
  262. Contraceptive awareness and knowledge of use.
  263. Contraceptive counseling.
  264. Contraceptive effective against HIV transmission found safe in recent testing.
  265. Contraceptive efficacy and safety studies of a novel microemulsion-based lipophilic vaginal spermicide.
  266. Contraceptive implant matches effect of IUDs and sterilisation.
  267. Contraceptive implants update.
  268. Contraceptive patch, ring: in U.S. by 2001?
  269. Contraceptive practice in diabetic women in Algeria : results of a survey performed in a sample of 103 patients. [Pratique contraceptive des femmes diabétiques d'Algérie : résultats d'une enquête réalisée sur un échantillon de 103 patientes.]
  270. Contraceptive practice in Quirino Province, Philippines: experiences of side effects.
  271. Contraceptive practices of women after abortion in Turkey.
  272. Contraceptive projections and the donor gap.
  273. Contraceptive risk-taking in women and men facing legal abortion.
  274. Contraceptive security, information flow, and local adaptations: family planning Morocco. [Sécurité contraceptive, circulation de l'information et adaptations locales : le planning familial au Maroc.]
  275. Contraceptive security: toward a framework for a global assessment.
  276. Contraceptive services for adolescents.
  277. Contraceptive shortages loom in less developed countries.
  278. Contraceptive shortfall crisis is real, international leaders agree.
  279. Contraceptive use among Kuwaitis, 1984-1999.
  280. Contraceptive use among RP women down, says survey.
  281. Contraceptive use and family planning after labor in the European part of the Russian Federation: 2-year monitoring.
  282. Contraceptive use and method choice in Turkey.
  283. Dual vs. duel(ing) protection against unintended pregnancy and sexually transmitted infections: What is the best contraceptive approach?
  284. Economic issues and contraception. [Enjeux économiques et contraception.]
  285. The editor's workshop. The changing face of oral contraceptives in adolescent gynecology.
  286. Effect of oral and injectable contraceptives on serum electrolytes, weight and blood pressure.
  287. Effect of second and third generation oral contraceptives on lipid metabolism in the absence or presence of the factor V Leiden mutation.
  288. The effect of the progestagen component of the low-dose combined contraceptive pills on the resistance to activated protein C.
  289. The effect of tolterodine on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive containing ethinyl estradiol and levonorgestrel.
  290. Effect of water extracts of Bursera species on sperm aggregation: contraceptive potential.
  291. The effectiveness of national dissemination of updated reproductive health / family planning guidelines in Kenya. Final report.
  292. Effects of oral contraceptives on daily self-ratings of positive and negative affect.
  293. The effects of postmenopausal hormone replacement therapy and oral contraceptives on the endogenous estradiol metabolism.
  294. Effects of progestogen-only contraceptives on breast-feeding and infant growth.
  295. Emergency contraception "could cut abortions".
  296. Emergency contraception (pills)
  297. Emergency contraception (postcoital contraception)
  298. Emergency contraception -- direct from the pharmacist. [Contraception d'urgence - venant tout droit de la pharmacie.]
  299. Emergency contraception : going over the counter? [Contraception d'urgence : bientôt en vente libre ?]
  300. Emergency contraception around the world.
  301. Emergency contraception at a glance. How safe are ECPs and how do they work? [Contraception d'urgence au premier coup d'oil. Est-ce que les PCU sont sûrs et comment fonctionnent-ils.]
  302. Emergency contraception in Brazil: facilitators and barriers. [Anticoncepcao de emergencia no Brasil: facilitadores e barreiras.]
  303. Emergency contraception in the community [letter]
  304. Emergency contraception, safety net institutions on APHA agenda.
  305. Emergency contraception.
  306. Emergency contraception. [Contracepçao de emergência.]
  307. Emergency contraception: a matter of dedication and access.
  308. Emergency contraception: a right of all women. [Anticoncepción de emergencia: un derecho de todas las mujeres.]
  309. Emergency contraception: an important and underutilized contraceptive option.
  310. Emergency contraception: an important option for women in situations of violence.
  311. Emergency contraception: knowledge and attitudes of health care providers in a health maintenance organization.
  312. Emergency contraception: Mostly successes, but still some threats [editorial]
  313. Emergency contraception: Who are the users?
  314. Emergency contraceptive pills can prevent abortion.
  315. Emergency contraceptive pills should be available over-the-counter.
  316. Emerging voices: Mexican youth talk about the environment, the future, and international family planning funding. [Voces nuevas: los jóvenes mexicanos hablan sobre el medio ambiente, el futuro y la financiación internacional de la planificación familiar.]
  317. Evaluate critically the cardiovascular risks of oral contraceptives. MRCOG Part II model essay answer.
  318. Evaluating the safety of medicines, with particular reference to contraception.
  319. Evaluation of a contraceptive device with MR imaging.
  320. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder.
  321. Expanded urban family planning services.
  322. The experience of the Tunisian family planning program, 1956-1996. [L'experience du programme tunisien de planification familiale (1956-1996)]
  323. Experimental gingivitis in women using oral contraceptives.
  324. Factors influencing the use of contraception: a study of rural Delhi.
  325. Factors influencing women's satisfaction with birth control methods.
  326. Family planning a human right, Guatemala.
  327. Family planning among adolescent mothers in an urban center of Cameroon. [Planning familial chez les adolescentes meres d'enfants dans un centre urbain du Cameroun.]
  328. Family planning and abortion : a human rights perspective. [Planning familial et avortement : point de vue des droits de la personne humaine.]
  329. Family planning choices and some characteristics of coitus interruptus users in Gemlik, Turkey.
  330. Family planning efforts "getting better".
  331. Family planning funding 2001.
  332. Family planning in grand multiparous women in Diyarbakir, Turkey, 1998: the factors affecting contraceptive use and choice of method.
  333. Family planning in Japanese society: traditional birth control in a modern urban culture. B. Abortion.
  334. Family planning in public rental districts. [Planeamento familiar em bairros de arrendamento publico.]
  335. A family planning market segmentation analysis: a first step in operationalizing contraceptive security policies in Romania.
  336. Family planning methods for the breastfeeding woman: lactational amenorrhea method.
  337. Family planning methods, knowledge and practices among the women of different income groups: a study of Chembur area, Mumbai.
  338. Family planning prevents abortion.
  339. Family planning profiles -- Nepal and Cameroon.
  340. Family planning programs and "charitable choice": are they compatible?
  341. Family planning saves women's lives.
  342. Family planning saves women's lives: the Nepalese evidences.
  343. Family planning services limit abortion: evidence from Bangladesh.
  344. Family planning the Taboy way.
  345. Family planning without doctors.
  346. Family planning. [Planification familiale.]
  347. FDA approves combined monthly injectable contraceptive.
  348. FDA approves contraceptive vaginal ring. Current design of etonogestrel / ethinyl estradiol contraceptive vaginal ring.
  349. FDA approves first hormonal vaginal contraceptive ring.
  350. Federal law urged as culmination of contraceptive insurance coverage campaign.
  351. The female athlete and contraceptive hormones. [La femme athlète et les hormones contraceptives.]
  352. Female contraception. [Contraccezione femminile.]
  353. A fertile future? In the developing world, access to existing contraceptives would save lives.
  354. Fertility and contraceptive dynamics in Ethiopia.
  355. Fertility awareness methods of family planning: the physiological background, methodology and effectiveness of fertility awareness methods. A CPD self-assessment test. Review.
  356. The financial impact of over-the-counter availability of oral contraceptive pills.
  357. Financing contraceptive supplies in developing countries: summary of issues, options, and experience.
  358. Follow-up and evaluation of a distance learning program for family planning service providers in Morocco.
  359. The future of contraception.
  360. The future of contraception: a pregnant pause.
  361. Gauging awareness, assessing concern: focus group findings on reactions to contraceptive supply shortages.
  362. GM-144, a novel lipophilic vaginal contraceptive gel-microemulsion.
  363. GPs and pharmacists agree about emergency contraception.
  364. Haemolysis and the combined oral contraceptive pill? [letter]
  365. Health benefits of oral contraceptives: update on endometrial cancer protection.
  366. Health for all in sight. The Navrongo Community Health and Family Planning Project.
  367. Hormonal and barrier methods of contraception, oncogenic human papillomaviruses, and cervical squamous intraepithelial lesion development.
  368. Hormonal contraception and migraine. FACT, Faculty Aid to CPD Topics review. A CPD self-assessment test. [Contraception hormonale et migraine. Analyse de FACT, Faculty Aid to CPD Topics (Aide de la Faculté concernant des sujets CPD). Test d'auto-analyse CPD.]
  369. Hormonal contraception and thromboembolic disease -- pathophysiologic findings and practical recommendations. [Hormonalni- antikoncepce a tromboembolicka nemoc -- patofyziologicka poznatky a prakticka doporucena-.]
  370. Hormonal contraception for adolescents. [Hormonale Kontrazeption bei Adoleszenten.]
  371. Hormonal contraception in the perimenopause. [Hormonale Kontrazeption in der Perimenopause.]
  372. Hostility, oral contraceptive use, and cardiovascular reactivity in women.
  373. How contraceptive use patterns differ by pregnancy intention: implications for counseling.
  374. How do rural Ivory Coast populations perceive family planning. [Comment les populations rurales ivoiriennes percoivent-elles la planification familiale?]
  375. How family planning and reproductive health services affect the lives of women, men, and children.
  376. The impact of side effects on family planning use among female clients of the public health services in Jamaica.
  377. The impact of structural adjustment programme on the acceptance of family planning programmes in Nigeria.
  378. The impacts of a family planning program on contraceptive / fertility behavior in Taiwan.
  379. Implant contraception.
  380. Improve information on oral contraceptives. [Améliorer l'information sur les contraceptifs oraux.]
  381. Improved use of contraceptives, attitudes toward pornography, and sexual harassment among female university students.
  382. Improving access to family planning through the private sector.
  383. Improving family planning use and quality of services in Nepal through the entertainment-education strategy. Summary and update of Field Report No. 12.
  384. Increased awareness needed to reach full potential of emergency contraception.
  385. Indian women's groups protest at new contraceptive trial.
  386. Indigenous understanding of the workings of the body and contraceptive use amongest rural women in Bangladesh.
  387. The influence of mass media on current use of contraception in rural Bangladesh.
  388. Injectable long-acting contraceptives.
  389. An integrated path analysis approach for the study of determinants of family planning acceptance in Orissa.
  390. Integrating issues of sexuality into family planning counseling in Egypt.
  391. Intention not to use contraception: a comparative study of northern and southern states of India.
  392. Intrauterine contraceptive device (IUCD): socio-demographic characteristics of acceptors, acceptability and effectiveness in a teaching hospital in Nigeria.
  393. Introducing emergency contraception in Bangladesh: a feasibility study.
  394. An investigation into contraceptive use in Assam.
  395. Is there a role for contraceptive vaccines in fertility control?
  396. Is there evidence of birth control in late imperial China?
  397. Islam, women and family planning: a primer.
  398. Joint circular on the guidance of development and implementation of conventions and rules of villages regarding population and family planning policy.
  399. Knowledge of emergency contraception among pharmacists and doctors in Durban, South Africa.
  400. Knowledge, attitude and practice of family planning amongst women in a high density low income urban [area] of Enugu, Nigeria.

     

  401. LAM (lactational amenorrhea method): a postpartum temporary contraceptive option for women who breastfeed. Training module for health and family planning service providers.
  402. Lamotrigine plasma levels reduced by oral contraceptives.
  403. A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in Germany.
  404. The levonorgestrel intra-uterine system : therapeutic application in family planning. [Le système intra-utérin levonorgestrel : application thérapeutique en planning familial.]
  405. The levonorgestrel intrauterine system: an effective new contraceptive option.
  406. Liver adenoma and focal nodular hyperplasia associated with oral contraceptives.
  407. The long term and permanent family planning methods marketing strategy. Resource package for a DISH best practice.
  408. The long-acting progestogen-only contraceptive injections : an update. [Injections de contraceptif à base de progestogène seulement, et à effet de longue durée : dernières informations.]
  409. Low-dose oral contraception and bone density. [Niedrig dosierte orale Kontrazeptiva und Knochendichte.]
  410. Low-dose oral contraceptive use and the risk of myocardial infarction.
  411. Low-dose oral contraceptives: protective effect on ovarian cancer risk.
  412. Magnitude and variability of sequential estradiol and progesterone concentrations in women using depot medroxyprogesterone acetate for contraception.
  413. Male attitudes to family planning in the era of HIV / AIDS: evidence from KwaZulu-Natal, South Africa.
  414. Male contraception in adolescence. [Contraccezione maschile nell'adolescenza.]
  415. Male contraception.
  416. Male contraceptive technology.
  417. Male involvement in family planning and reproductive health through sports.
  418. Male involvement in family planning: a knowledge, attitude, belief and practice study of Govandi.
  419. Male participation in family planning. An evaluation study of no-scalpel vasectomy project, Andhra Pradesh.
  420. Male participation in family planning. An evaluation study of no-scalpel vasectomy project, Haryana.
  421. Male participation in family planning. An evaluation study of no-scalpel vasectomy project, Madhya Pradesh.
  422. Male participation in family planning. An evaluation study of no-scalpel vasectomy project, Maharashtra.
  423. Male participation in family planning. An evaluation study of no-scalpel vasectomy project, Manipur.
  424. Male participation in family planning. An evaluation study of no-scalpel vasectomy project, Orissa.
  425. Managing fear, giving hope. HIV / AIDS and family planning behavior change communication guidelines for urban youth.
  426. Managing the transition from oral contraceptives to hormone replacement therapy.
  427. A matter of conscience. Catholics on contraception.
  428. MEASURE DHS+ model "A" questionnaire with commentary for high contraceptive prevalence countries.
  429. MEASURE DHS+ model "B" questionnaire with commentary for low contraceptive prevalence countries.
  430. Measuring the contraceptive efficacy of Persona.
  431. Mechanism of action of hormonal preparations used for emergency contraception: a review of the literature.
  432. Media campaign in Cameroon linked with increased contraceptive use. [Press release] [Campagne médiatique au Cameroun en rapport avec l'intensification de l'usage du contraceptif] [Communiqué de presse.]
  433. Medicaid support for family planning in the managed care era.
  434. Medical-eligibility criteria for contraceptive use.
  435. Meeting the Reproductive Health Challenge: Securing Contraceptives, and Condoms for HIV / AIDS Prevention, Istanbul, Turkey, 3-5 May 2001. Report on the meeting.
  436. Men's participation in contraception from the woman's perspective. [Participacao masculina na contracepcao pela otica feminina.]
  437. Methods for administration of family planning technical services.
  438. Mexico. Contraceptive logistics system (DGSR): review of accomplishments and lessons learned. [México. Sistema logístico de anticoncepción (DGSR): reseña de logros y lecciones aprendidas.]
  439. Mini-pills (progesterone-only oral contraceptives)
  440. Mock family planning clinics: community-based teaching on contraception for medical students.
  441. Mood changes in adolescents using depot-medroxyprogesterone acetate for contraception: a prospective study.
  442. Mothers' aspirations for their daughters' education as correlate of contraceptive use among women of Punjab, Pakistan.
  443. On the dynamics of contraceptive use in Pakistan.
  444. Ovarian cancer, oral contraceptives, and BRCA mutations [letter]
  445. Ovarian cancer, oral contraceptives, and BRCA mutations [letter]
  446. Pakistan Contraceptive User Satisfaction and Longevity Study 1997. Final report.
  447. Pakistan Reproductive Health and Family Planning Survey (2000-01). Preliminary report.
  448. Pangasinan. Church, local government launch campaign on family planning.
  449. Patient communication and counseling on contraception and hormone replacement therapy.
  450. Pattern of contraceptive use in Quetta.
  451. Perceived and actual side effects of oral contraception.
  452. Perceptions of parenthood among young adults: implications for career and family planning.
  453. Pharmacologic characteristics of progestins used for contraception and hormone replacement therapy, including new transdermal technologies.
  454. Pilot program tests distributing emergency contraception without a prescription.
  455. The Planet campaign. Bringing international family planning to a U.S. audience.
  456. Planned parenthood develops its own condom. [La planification parentale développe son propre préservatif.]
  457. Population policies, family planning programs, and fertility: the record.
  458. Post-attack economic woes create challenges for family planning advocates.
  459. Postcoital contraception.
  460. Postcoital contraception. [Postkoital antikonsepsjon.]
  461. Postcoital contraception. [Postkoitalni kontracepce.]
  462. Postcoital emergency contraception. [Postkoitale Notfall-Kontrazeption.]
  463. Practical monitoring system for Project INS/99/P01 -- family planning support. Final report.
  464. Practices of prescribing oral contraceptives in Poland.
  465. Predicting intended contraception in a sample of Ethiopian female adolescents: the validity of the theory of planned behavior.
  466. Preferential prescribing of type of combined oral contraceptive pill by general practitioners to teenagers with acne.
  467. Prescription contraceptives: benefit whose time has come?
  468. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives.
  469. Profiling usage and users of emergency contraceptive pills in Thailand.
  470. Programming for emergency contraception at a glance. Introducing EC into the community : the story of the Consortium for Emergency Contraception. [Programmation en vue de la contraception d'urgence au premier coup d'oil. Introduction de la CU dans la communauté : histoire du Consortium pour la Contraception d'Urgence.]
  471. Promoting dual protection within family planning services in Nigeria. Research summary.
  472. Promoting emergency contraception.
  473. Properties of a new, long-lasting vaginal delivery system (LASRS) for contraceptive and antimicrobial agents.
  474. Prophylaxis. Contraceptive safe and effective against HIV transmission.
  475. Proposed new rules for Medicaid managed care could impede family planning access.
  476. A proton NMR study of the effect of a new intravasal injectable male contraceptive RISUG on seminal plasma metabolites.
  477. Providers examine teen contraceptive use.
  478. Provision of emergency contraception in family planning clinics in the Val de Marne, 1998. [Delivrance de la contraception d'urgence, en 1998, dans les centres de planification et d'education familiale (CPEF) du Val de Marne.]
  479. Provision of emergency contraception in general practice and confidentiality for the under 16's: results of a postal survey by general practitioners in Avon.
  480. Putting risk in perspective: an evidence-based approach to selected risks associated with the use of oral contraception.
  481. A qualitative assessment of condom use decisions by female adolescents who use hormonal contraception.
  482. A qualitative study of the views of women aged 18-29 on over-the-counter availability of hormonal emergency contraception.
  483. Quality of care in family planning clinics in Jamaica. Do clients and providers agree?
  484. Randomized controlled trials in Contraception: the need for "CONSORT" guidelines [editorial]
  485. A randomized, controlled trial of a low-dose contraceptive containing 20 micrograms of ethinyl estradiol and 100 micrograms of levonorgestrel for acne treatment.
  486. Recommendation for prescription of postcoital contraception. [Doporuceni k predpisu postkoitalni kontracepce.]
  487. Redux: Is the oral contraceptive pill an abortifacient?
  488. The relationship between prenatal care and subsequent modern contraceptive use in Bolivia, Egypt and Thailand. [Relación entre controles prenatales y uso subsiguiente de métodos anticonceptivos modernos en Bolivia, Egipto y Tailandia.]
  489. Response to Joel Goodnough MD, "Redux: Is the oral contraceptive pill an abortifacient?"
  490. Retention of training skills in family planning trainers: results of a 1997 trainer followup assessment in Zimbabwe.
  491. Retrospective vs. prospective coital frequency and menstural cycle length in a contraceptive effectiveness trial.
  492. Revealing the "secrets" of emergency contraception. [Revelación de los "secretos" de la anticoncepción de emergencia.]
  493. A review of family planning services by general practitioners in a Health Board region.
  494. Rise in contraceptive use and decline in fertility continues: NIPS survey.
  495. The risks of oral contraceptive pills.
  496. The role of hepatobiliary scintigraphy in the follow-up of benign liver tumors secondary to oral contraceptive use.
  497. The role of MCH and family planning services in HIV / STD control: is integration the answer?
  498. Routine provision of emergency contraception to teens and subsequent condom use: a preliminary study [letter]
  499. Seeking ways to improve emergency contraception.
  500. Sensitive LH and FSH assays for monitoring low serum levels in men undergoing steroidal contraception.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.